We are live on ! Find out more
VVM

Versant Venture Management Portfolio holdings

AUM $141M
1-Year Est. Return 190.82%
This Fund
S&P 500
This Quarter Est. Return
-2.89%
1 Year Est. Return
+190.82%
3 Year Est. Return
+375.7%
5 Year Est. Return
+81.85%
10 Year Est. Return
+4,735.29%
AUM
$58.7M
AUM Growth
-$6.58M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRSP icon
1
CRISPR Therapeutics
CRSP
$4.68B
$32.6M 55.55%
498,558
– –
GRTS
2
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$9.15M 15.6%
3,561,150
– –
PASG icon
3
Passage Bio
PASG
$14.7M
$6.2M 10.57%
247,988
– –
ADVM
4
DELISTED
Adverum Biotechnologies
ADVM
$4.82M 8.21%
506,823
– –
ALGS icon
5
Aligos Therapeutics
ALGS
$26.3M
$2.55M 4.35%
92,815
– –
CBAY
6
DELISTED
Cymabay Therapeutics
CBAY
$1.9M 3.24%
543,753
– –
UTRS
7
DELISTED
Minerva Surgical, Inc. Common Stock
UTRS
$1.33M 2.27%
83,685
– –
CLVS
8
DELISTED
Clovis Oncology, Inc.
CLVS
$121K 0.21%
101,855
– –

Similar funds

POIA
Pin Oak Investment Advisors Houston, Texas $141M AUM 20.83% 1-Year Est. Return
MAM
Maytree Asset Management Hong Kong $141M AUM 114% 1-Year Est. Return
TM
TFJ Management Somerville, Massachusetts $141M AUM 9.28% 1-Year Est. Return
IA
IF Advisors San Antonio, Texas $141M AUM
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
RB
Renasant Bank Tupelo, Mississippi $141M AUM 16.9% 1-Year Est. Return
YEPX
Yorktown Energy Partners XI New York $142M AUM 130.51% 1-Year Est. Return
CFGW
Chancellor Financial Group WB Wilkes-Barre, Pennsylvania $141M AUM 23.22% 1-Year Est. Return

Versant Venture Management's Q3 2022 Portfolio in Review

As of Q3 2022, Versant Venture Management held 8 positions worth $58.7M, down 10% from $65.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2022: portfolio turnover was 0%. Versant Venture Management opened no new positions and made no exits, leaving the 8-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Versant Venture Management's ten largest holdings make up 100% of its $58.7M portfolio in Q3 2022.
  • Versant Venture Management opened 0 new positions and closed 0 in Q3 2022.
  • Versant Venture Management's portfolio value fell 10% quarter-over-quarter to $58.7M.

Based on Versant Venture Management's 13F filing for Q3 2022, filed 10 Nov 2022.